| Market Cap | ₹14,084Cr |
| ROE | 12.88% |
| P/E Ratio(TTM) | 27.47 |
| EPS(TTM) | 21.13 |
| P/B Ratio | 3.54 |
| Dividend Yield | 0.26% |
| Industry P/E | 33.18 |
| Book Value | 164.12 |
| Debt to Equity | 0.45 |
| Face Value | 1 |
| Parent Organisation | Granules India Limited |
| Managing Director | Dr. K.V.S. Ram Rao |
| Founded | 1991 |
| NSE Symbol | GRANULES |
| FUND NAME | AUM(%) |
|---|---|
| Tata Large Cap Direct Plan Growth | 1.05% |
| Tata Mid Cap Direct Plan Growth | 1.03% |
| Axis Value Fund Direct Growth | 0.95% |
| Edelweiss Balanced Advantage Fund Direct Growth | 0.92% |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.94 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 32.07 | ||
| Wockhardt | NA (0.00%) | -439.39 | ||
| Cohance Lifesciences | NA (0.00%) | 64.75 |